Atara Biotherapeutics, Inc. logo

Atara Biotherapeutics, Inc. (0HIY)

Market Closed
17 Jul, 15:30
LSE LSE
$
8. 49
0
0%
$
- Market Cap
- P/E Ratio
- Div Yield
3,876 Volume
-2.6 Eps
$ 8.49
Previous Close
Add Transaction
Day Range
8.2 8.83
Year Range
4.02 19.05
Want to track 0HIY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Atara Biotherapeutics, Inc. (0HIY) Statistics

Valuation metrics

Market Cap -
Enterprise value 77.33M
Trailing P/E (ttm) -12.71
Forward P/E -
PEG ratio 0.02
Price/Sales (ttm) 3.27
Price/Book (mrq) -3.17
Enterprise Value/Revenue 3.34
Enterprise Value/EBITDA -14.11

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 5.09K
Average volume (90 days) 19.55K

Price summary

52-Week low 4.02
52-Week high 19.05
Beta -
50-Day moving average 10.08
200-Day moving average 7.48

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 0.04:1
Last split Date 20 Jun 2024

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -0.41%
Operating margin -0.27%

Operational effectiveness

Return on assets -0.47%
Return on equity 0.26%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 1.64
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.67
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 0.59
Total debt (mrq) -
Total Debt/Equity (mrq) -0.27
Current ratio (mrq) 2.16%
Book value per share (mrq) -2.65

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -